Zacks Small Cap Estimates SeaStar Medical FY2025 Earnings

SeaStar Medical Holding Corporation (NASDAQ:ICU) – Analysts at Zacks Small Cap issued their FY2025 earnings estimates for SeaStar Medical in a research report issued to clients and investors on Tuesday, January 13th. Zacks Small Cap analyst D. Bautz expects that the company will earn ($5.95) per share for the year. Zacks Small Cap also issued estimates for SeaStar Medical’s Q4 2025 earnings at ($0.97) EPS, FY2026 earnings at ($2.11) EPS and FY2027 earnings at ($1.63) EPS.

A number of other analysts have also recently weighed in on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of SeaStar Medical in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of SeaStar Medical to a “hold” rating in a report on Saturday, January 10th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

SeaStar Medical Stock Down 1.6%

Shares of SeaStar Medical stock opened at $2.53 on Thursday. SeaStar Medical has a 12-month low of $2.20 and a 12-month high of $30.70. The stock has a 50 day moving average price of $3.05 and a two-hundred day moving average price of $5.74. The stock has a market capitalization of $9.12 million, a P/E ratio of -0.15 and a beta of -1.00.

SeaStar Medical (NASDAQ:ICU) last released its quarterly earnings results on Thursday, November 13th. The company reported ($1.30) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.50) by $0.20. The company had revenue of $0.18 million during the quarter, compared to the consensus estimate of $0.25 million. SeaStar Medical had a negative return on equity of 414.50% and a negative net margin of 1,551.08%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. XTX Topco Ltd grew its position in SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after buying an additional 48,674 shares in the last quarter. Trinity Financial Advisors LLC lifted its position in shares of SeaStar Medical by 233.3% in the 3rd quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock worth $28,000 after acquiring an additional 35,000 shares during the period. Finally, Millennium Management LLC acquired a new stake in shares of SeaStar Medical during the 3rd quarter worth approximately $102,000. Institutional investors own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.